Share Awards, Director Dealings & Issue of Equity

Summary by AI BETAClose X

Duke Capital Limited has approved the grant of 4,589,000 conditional performance share awards under its Long-Term Incentive Plan, with 1,222,000 awarded to Neil Johnson and 1,222,000 to Charlie Cannon Brookes, subject to total shareholder return, cash available for distribution, and continuous employment. Additionally, 453,745 PSAs from the financial year ended March 31, 2023, and 772,166 PSAs from the financial year ended March 31, 2025, have vested, resulting in the transfer of 1,225,911 ordinary shares to beneficiaries, with 150,000 shares sold at 27.55 pence to cover tax liabilities. Following these transactions, Neil Johnson holds 8,066,427 ordinary shares and Charlie Cannon Brookes holds 13,637,148 ordinary shares. The company has also issued 1,552,857 new ordinary shares into its Employee Benefit Trust, bringing the total ordinary shares in issue to 511,368,630 upon expected admission on August 18, 2026.

Disclaimer*

Duke Capital Limited
17 August 2026
 

17 August 2026

Duke Capital Limited

 

("Duke Capital", "Duke" or the "Company")

 

Performance Share Awards

Director/PDMR Dealings and Issue of Equity

 

Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, announces that the Company's Remuneration Committee has approved the grant of a total of 4,589,000 conditional rights to acquire ordinary shares of no par value (“PSAs”) under the Company's Long-Term Incentive Plan ("LTIP").

 

PSAs for the financial year to 31 March 2026 have been granted as follows:

 

Neil Johnson

1,222,000

Charlie Cannon Brookes

1,222,000

Other employees (non-PDMRs)

2,145,000

Total

4,589,000

 

The PSAs vest after a period of three years and are subject to various performance conditions outlined in the Company's admission document (and available on the Company's website) and set by the Remuneration Committee, all in accordance with the LTIP rules. The PSAs will be subject to the following conditions:

  1. 25% based on growth in total shareholder return ("TSR"), where TSR can be defined as the returns generated by shareholders based on the combined value of the dividends paid out by the Company and the share price performance over the period in question
  2. 25% on growth in total cash available for distribution per share ("TCAD per Share"); and
  3. 50% on continuous employment (“Time-based”). The time-based LTIPs will vest equally over three tranches at the end of years 1, 2 and 3.

 

Vesting of PSAs, transfer from Employee Benefit Trust (“EBT”) & Director/PDMR interests

 

The Company announces that a total of 453,745 PSAs, previously granted under the Company's LTIP in relation to the financial year ended 31 March 2023 have vested, representing 12.4% of the PSAs granted at that time.

 

The Company also announces that a total of 772,166 PSAs, previously granted under the Company's LTIP in relation to the financial year ended 31 March 2025 have vested, representing 16.7% of the PSAs granted at that time.

 

Accordingly, 1,225,911 existing ordinary shares held within the EBT have now been transferred to the beneficiaries, of which 150,000 shares have been sold at a price of approximately 27.55 pence in order to meet certain tax liabilities arising upon issue of the PSAs. Further information is set out within the PDMR notification tables below.

 

Following the various transactions detailed above, the following Directors / PDMRs have the following total interest in ordinary shares:

 

 

Director/PDMR

Total ordinary shares held

Neil Johnson (1)

8,066,427

Charlie Cannon Brookes (2)

13,637,148

 

 

(1)  Mr Johnson is Abingdon Capital Corporation's sole voting shareholder which legally owns 2,123,149 ordinary shares included within this figure.

 

(2)  Mr Cannon Brookes a Director and shareholder of Arlington Asset Management Limited ("Arlington"). This figure includes 5,818,181 ordinary shares legally owned by Arlington.

  

Total voting rights and EBT share issue

 

In order to maintain an appropriate level of headroom within the Company's EBT, the Company has issued 1,552,857 new ordinary shares into the Duke Capital EBT, ownership of which shall be transferred, in part or in full, to individual beneficiaries, subject to achievement of the relevant criteria following the vesting period. Application has been made for these 1,552,857 shares to be admitted to trading on AIM, which is expected to occur on 18 August 2026 ("Admission"). 

 

Following Admission and transfer of the 1,225,911 shares to LTIP beneficiaries, the Company will have 511,368,630 ordinary shares in issue admitted to trading on AIM, of which 6,626,313 will be held by the EBT. This figure (511,368,630) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information, please visit www.dukecapital.com or contact:

 

Duke Capital Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 231 816

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Stephen Keys / Callum Davidson / Michael Johnson 

+44 (0) 207 220 0500

 

 

 

 

Canaccord Genuity Limited

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

 

Notifications of dealings by PDMRs:

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Neil Johnson

2.

Reason for notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Capital Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value
 

GG00BYZSSY63

b)

Nature of transaction

Grant of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

1,222,000

d)

Aggregated Information

n/a

e)

Date of transaction

Award date: 17 August 2026

f)

Place of transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Neil Johnson

2.

Reason for notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Capital Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value
 

GG00BYZSSY63

b)

Nature of transaction

Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

329,555

d)

Aggregated Information

n/a

e)

Date of transaction

17 August 2026

f)

Place of transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Neil Johnson

2.

Reason for notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Capital Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value
 

GG00BYZSSY63

b)

Nature of transaction

Sale of ordinary shares following vesting of conditional performance share awards under LTIP to cover tax liability

c)

Price(s) and volume(s)

Price(s)

Volume(s)

27.55p per share

150,000

 

 

d)

Aggregated Information

N/A – single transaction

e)

Date of transaction

14 August 2026

f)

Place of transaction

London Stock Exchange - AIM

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Charlie Cannon Brookes

2.

Reason for notification

a)

Position/Status

Chief Investment Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Capital Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value
 

GG00BYZSSY63

b)

Nature of transaction

Grant of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

1,222,000

d)

Aggregated Information

n/a

e)

Date of transaction

Award date: 17 August 2026

f)

Place of transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Charlie Cannon Brookes

2.

Reason for notification

a)

Position/Status

Chief Investment Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Capital Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value
 

GG00BYZSSY63

b)

Nature of transaction

Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

318,967

d)

Aggregated Information

n/a

e)

Date of transaction

17 August 2026

f)

Place of transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings